Earnings ·
Baird Medical posts $13,499 net income for six months ended June 30, 2026, a turnaround from prior year loss
BDMDBaird Medical Investment Holdings Ltd
Baird Medical Investment Holdings Limited reported a net income of $13,499 for the six months ended June 30, 2026, a significant turnaround from an $11.4 million net loss in the prior year period. Revenues increased 24.6% to $9.9 million, driven by $4.8 million in new technology licensing revenue that partially offset a $3.0 million decline in microwave ablation device sales. Adjusted EBITDA turned positive at $4.0 million compared to negative $3.3 million previously. The company also announced a subsequent event financing of approximately $4 million via senior 8% convertible promissory notes issued on September 8, 2026. Baird Medical Investment Holdings Limited operates in the medical technology industry, specializing in non-invasive thyroid treatment solutions and microwave ablation devices.